Tweets
Colchicine & Statins: A significant interaction?
Colchicine is frequently used in rheumatologic practice. Current ACR guidelines for gout management support anti-inflammatory prophylaxis, including colchicine, during initiation and uptitration of urate-lowering therapy https://t.co/BFF9UTuLIl
Dr. John Cush @RheumNow ( View Tweet )
3 hours 36 minutes ago
Single center study of Probiotics in #PsA showed no benefit. 66 moderately active PsA pts (PASDAS>3.2) on stable Tx: Rx probiotic vs PBO x 12 wks. 56 pts analyzed, PASDAS <3 responders: 43% probiotic vs 65% PBO (P 0.167), w/ no change in gut permeability markers or stool https://t.co/0JUZ8SrRuw
Dr. John Cush @RheumNow ( View Tweet )
5 hours 36 minutes ago
92 early (<2 yrs) systemic sclerosis pts were treated with #MTX; 79% diffuse SSc. At 3 mos, 34% of dcSSc ≥25% reduction in mRSS - increasing to 612% a@ 24 mos (29% at 24 mos ITT w/ non-responder imputation). GC did not improve skin. Dz progression seen w/ 75% of MTX monoTx D/C https://t.co/w5Gc3ntej0
Dr. John Cush @RheumNow ( View Tweet )
7 hours 36 minutes ago
🚨NOW IN THE POSTER HALL: Long-Term Safety of a JAKi in Clinical Trial and Real-World Settings Across >21,000 Patient-Years
Check out the data in RA, PsA, AS, and nr-axSpA presented at EULAR 2026: https://t.co/SFqBCUIxio
Sponsored by AbbVie Medical Affairs + Health Impact. https://t.co/AgOGo2jtSc
Dr. John Cush @RheumNow ( View Tweet )
9 hours 34 minutes ago
"Perfection is not attainable, but if we chase perfection we can catch excellence."
- Vince Lombardi https://t.co/KgQGp6mKlH
Dr. John Cush @RheumNow ( View Tweet )
10 hours ago
Symptomatic hand OA (HOA) increased signif in past decade in the Netherlands (esp women & older adults). PCP EHR study of 1.8 million Dutch patients ≥30 yrs. Betw 2013 & 2023, prevalence incr 65% (5.7 to 9.4%); incidence rose 20% (7.1 to 8.5/1000PY) https://t.co/HyqdwJ70y4 https://t.co/7fBngLO5w0
Dr. John Cush @RheumNow ( View Tweet )
1 day ago
Univ Toronto lupus clinic study of 165 #SLE pts w/ Bx-proven LN (age 35.3 yrs; Dz dur 6.2 years). Half on antimalarial Rx. Being on HCQ did not alter Renal Bx outcomes (prolif GN, NIH AI, NIH CI, IFTA score. (But is known to improve renal outcomes) https://t.co/oQ0CgK7rXm https://t.co/PZX31wOPmL
Dr. John Cush @RheumNow ( View Tweet )
1 day ago
Can DMARD Doses Be Safely Reduced for RA Patients?
Close to 90% of patients with rheumatoid arthritis (RA) well controlled on targeted therapies were able to take 50% dosage reductions without experiencing worsened disease activity in a randomized trial, South Korean https://t.co/MyjZdRaGb4
Dr. John Cush @RheumNow ( View Tweet )
1 day ago
In early RA, initial b/tsDMARDs are better than MTX. Metanalysis of 29 RCTs (13387 pts), Vs MTX alone, initial b/tsDMARDs + MTX signif incr DAS28 remission 2 6 mos (RR 1.62) & 12 mos (RR 1.54). Benefits greater w/ higher baseline Dz, seropositivity https://t.co/exwVOc08xR https://t.co/00UXGTGPaH
Dr. John Cush @RheumNow ( View Tweet )
1 day ago
Kenneth G. Saag, M.D., https://t.co/TJOX58X5d5., Named North American Editor-in-Chief of Osteoporosis International; Dr. Saag also will oversee Archives of Osteoporosis in collaboration with the International Osteoporosis Foundation (IOF). Ken is a professor of medicine and https://t.co/KouJoStW5C
Links:
Dr. John Cush @RheumNow ( View Tweet )
2 days ago
Colchicine & Statins: A significant interaction?
Colchicine is frequently used in rheumatologic practice. Current ACR guidelines for gout management support anti-inflammatory prophylaxis, including colchicine, during initiation and uptitration of urate-lowering therapy https://t.co/eyDbfpQajN
Dr. John Cush @RheumNow ( View Tweet )
2 days ago
Surgery for 1st MTP Osteoarthritis
Hallux rigidus, or osteoarthritis of the first metatarsophalangeal joint (MTPJ), is common, but treatment options and long-term outcomes remain poorly understood. A 12-month clinical trial showed that first MTPJ arthrodesis (compared to https://t.co/fHda4GK4vA
Dr. John Cush @RheumNow ( View Tweet )
2 days ago
Single center study of Probiotics in #PsA showed no benefit. 66 moderately active PsA pts (PASDAS>3.2) on stable Tx: Rx probiotic vs PBO x 12 wks. 56 pts analyzed, PASDAS <3 responders: 43% probiotic vs 65% PBO (P 0.167), w/ no change in gut permeability markers or stool https://t.co/g6icpjuQOU
Dr. John Cush @RheumNow ( View Tweet )
2 days ago
UK survey study of 6607 autoimmune dz pts (91% female) saw females had longer Dx delays, more HCP visits, & signif more often told their Dz attributed to psychiatric (43% vs 33%: OR 1.56) or psychosomatic causes (34% vs 21%; OR 1.87). Females had slightly more misdiagnoses (48% https://t.co/tGhiWCSPy9
Dr. John Cush @RheumNow ( View Tweet )
2 days ago
Study of Prognostic Nutritional Index (PNI) in 984 RA pts shows PNI is independently inversely corelated w/ RA dz activity, esp. PNI <45. PNI = ser albumin & lymphocyte count calculation (10 × s albumin [g/dL]) + (0.005 × lymphocyte count/mm³]). Other studies have shown modest https://t.co/AV3AGXwSfg
Dr. John Cush @RheumNow ( View Tweet )
2 days ago


